MedTech Dive

Our goal is to give busy professionals a quick overview of the medtech industry in just 60 seconds. We share the latest industry news and offer original insights. Our editorial team works throughout the day to analyze key news stories and produce detailed feature articles. Additionally, you can explore our site for information on industry events, job opportunities, and more.

National, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#377457

United States

#162782

Health/Health

#3175

Traffic sources

Monthly visitors

Articles

Q’Apel recalls clot removal device in response to FDA warning letter

1 week ago | medtechdive.com | Nick Paul Taylor

This audio is auto-generated. Please let us know if you have feedback. Q’Apel Medical has recalled a device for removing blood clots in the brain over an issue linked to two injuries, the Food and Drug Administration said Tuesday. The company asked customers to return Hippo 072 Aspiration Systems and Cheetah Delivery Tools after receiving a warning letter in which the FDA raised concerns about the device’s tip.
Medtronic training pact includes Hugo robot, cardiac ablation tech

1 week ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Medtronic unveiled a collaboration Tuesday to integrate its technologies at IRCAD North America, a non-profit subsidiary of Atrium Health focused on surgical education, research and innovation. Founded in Strasbourg, France, in 1994, IRCAD now has centers around the world that offer hands-on training in minimally invasive surgery.
Dexcom recalls more than 2 million CGM receivers for lack of audible alarm

1 week ago | medtechdive.com | Elise Reuter

A problem with Dexcom’s receivers for its glucose sensors may cause people to not get an audible alert for low or high blood sugar levels, the Food and Drug Administration said in an enforcement report posted Monday. More than 2 million devices are affected by the Class I recall, the highest risk category. The receiver, a handheld device that gives glucose readings, may not provide an audible alert due to a manufacturing problem.
SS Innovations’ robot used in its first cardiac surgery in Americas

1 week ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Surgical robot developer SS Innovations International said Monday the first robotic cardiac surgery in the Americas using its SSi Mantra 3 system was performed at Interhospital in Guayaquil, Ecuador. The robotic atrial septal defect closure procedure repaired a hole between the upper two chambers of the patient’s heart.
Anne Wojcicki wins bid to buy back 23andMe for $305M

1 week ago | medtechdive.com | Elise Reuter

Anne Wojcicki, co-founder and former CEO of 23andMe, will buy back “substantially all” of the genetic testing firm's assets, 23andMe announced Friday. A bankruptcy court must still approve the sale. The nonprofit TTAM Research Institute — an acronym for 23andMe — outbid Regeneron with a purchase price of $305 million. Biotechnology firm Regeneron had offered $256 million, and the company was selected as the backup bidder, according to the announcement.
Zyno recalls infusion pumps over unvalidated software

1 week ago | medtechdive.com | Nick Paul Taylor

Zyno Medical has recalled infusion pumps that shipped with software that had not undergone verification and validation testing, the Food and Drug Administration said Monday. The company released the Z-800 pumps with incorrect software versions. The software created a risk of incorrect air-in-line detection and audio alarms that could cause serious harm. Zyno has not reported any serious injuries or deaths.
Centerline recalls guidewire over risk of coating being left in patients

1 week ago | medtechdive.com | Nick Paul Taylor

This audio is auto-generated. Please let us know if you have feedback. Centerline Biomedical has recalled guidewires used in vascular procedures over a fault that could cause serious injury or death, the Food and Drug Administration said Friday. The company has asked customers to return devices from the affected lots because the coating can come off during the procedure and be left inside the patient. No customers have reported serious injuries or deaths associated with the fault.
Abbott’s new diabetes leader on latest sensors, partnerships and Type 2 coverage

2 weeks ago | medtechdive.com | Elise Reuter

Abbott has been growing its diabetes business, striking partnerships and expanding its continuous glucose monitors to more people with Type 2 diabetes. Meanwhile, the company is developing a new type of sensor, one that can detect both glucose and ketones. Abbott also partnered last year with competitor Medtronic, agreeing to that will specifically work with Medtronic’s insulin pumps, pens and automated insulin delivery algorithms.
Quest partners with MD Anderson to develop cancer risk blood test

2 weeks ago | medtechdive.com | Nick Paul Taylor

Quest Diagnostics has partnered with The University of Texas MD Anderson Cancer Center to develop a cancer risk blood test. The collaboration, which Quest disclosed Tuesday, builds on MD Anderson’s research into protein biomarkers that may indicate a patient is at high risk of cancer diagnosis in the coming years. MD Anderson’s approach is potentially a cheaper way than liquid biopsies to find patients who would benefit from conventional screening, according to the announcement.
Medtronic recalls ventilators linked to 2 serious injuries, 1 death

2 weeks ago | medtechdive.com | Nick Paul Taylor

Medtronic has recalled ventilators and asked customers to stop using the devices because of a fault linked to two serious injuries and one death, the company said Wednesday. Affected Newport HT70 and HT70 Plus ventilators can shut down during use or fail to effectively sound the shutdown alert alarm. The company also recalled certain related Newport service parts. There have been 63 medical device reports about the problem.